Soleno Therapeutics (SLNO) Cash from Operations Growth (5y) (2018 - 2026)
Soleno Therapeutics (SLNO) Cash from Operations Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 468.11 Bn | 463.32 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.48 Bn | 115.23 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.30 Bn | 61.55 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - |
| 8 | Argenx Se | 55.66 Bn | 50.47 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.42 Bn | 34.41 Bn | 959.66 Mn |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.47% |
| Dec 31, 2025 | 55.50% |
| Sep 30, 2025 | 55.38% |
| Jun 30, 2025 | -14.12% |
| Mar 31, 2025 | -42.07% |
| Dec 31, 2024 | -36.43% |
| Sep 30, 2024 | -25.90% |
| Jun 30, 2024 | -35.30% |
| Mar 31, 2024 | -27.71% |
| Dec 31, 2023 | -21.60% |
| Sep 30, 2023 | -18.79% |
| Jun 30, 2023 | -11.45% |
| Mar 31, 2023 | -27.04% |
| Dec 31, 2022 | -80.58% |
| Sep 30, 2022 | -17.91% |
| Jun 30, 2022 | -3.84% |
| Mar 31, 2022 | -36.37% |
| Dec 31, 2021 | -20.61% |
| Sep 30, 2021 | -14.18% |
| Jun 30, 2021 | -14.68% |